Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals - PubMed (original) (raw)
. 2016 Jul 1;1(4):442-50.
doi: 10.1001/jamacardio.2016.1185.
Donglei Hu 2, Susan R Heckbert 3, Alvaro Alonso 4, Thomas A Dewland 1, Eric Vittinghoff 5, Yongmei Liu 6, Bruce M Psaty 7, Jeffrey E Olgin 1, Jared W Magnani 8, Scott Huntsman 2, Esteban G Burchard 9, Dan E Arking 10, Kirsten Bibbins-Domingo 11, Tamara B Harris 12, Marco V Perez 13, Elad Ziv 2, Gregory M Marcus 1
Affiliations
- PMID: 27438321
- PMCID: PMC5395094
- DOI: 10.1001/jamacardio.2016.1185
Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals
Jason D Roberts et al. JAMA Cardiol. 2016.
Abstract
Importance: White persons have a higher risk of atrial fibrillation (AF) compared with black individuals despite a lower prevalence of risk factors. This difference may be due, at least in part, to genetic factors.
Objectives: To determine whether 9 single-nucleotide polymorphisms (SNPs) associated with AF account for this paradoxical differential racial risk for AF and to use admixture mapping to search genome-wide for loci that may account for this phenomenon.
Design, setting, and participants: Genome-wide admixture analysis and candidate SNP study involving 3 population-based cohort studies that were initiated between 1987 and 1997, including the Cardiovascular Health Study (CHS) (n = 4173), the Atherosclerosis Risk in Communities (ARIC) (n = 12 341) study, and the Health, Aging, and Body Composition (Health ABC) (n = 1015) study. In all 3 studies, race was self-identified. Cox proportional hazards regression models and the proportion of treatment effect method were used to determine the impact of 9 AF-risk SNPs among participants from CHS and the ARIC study. The present study began July 1, 2012, and was completed in 2015.
Main outcomes and measures: Incident AF systematically ascertained using clinic visit electrocardiograms, hospital discharge diagnosis codes, death certificates, and Medicare claims data.
Results: A single SNP, rs10824026 (chromosome 10: position 73661450), was found to significantly mediate the higher risk for AF in white participants compared with black participants in CHS (11.4%; 95% CI, 2.9%-29.9%) and ARIC (31.7%; 95% CI, 16.0%-53.0%). Admixture mapping was performed in a meta-analysis of black participants within CHS (n = 811), ARIC (n = 3112), and Health ABC (n = 1015). No loci that reached the prespecified statistical threshold for genome-wide significance were identified.
Conclusions and relevance: The rs10824026 SNP on chromosome 10q22 mediates a modest proportion of the increased risk of AF among white individuals compared with black individuals, potentially through an effect on gene expression levels of MYOZ1. No additional genetic variants accounting for a significant portion of the differential racial risk of AF were identified with genome-wide admixture mapping, suggesting that additional genetic or environmental influences beyond single SNPs in isolation may account for the paradoxical racial risk of AF among white individuals and black individuals.
Figures
Figure 1
Manhattan Plots of Admixture Mapping for Incident Atrial Fibrillation Among Blacks from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D).
Figure 1
Manhattan Plots of Admixture Mapping for Incident Atrial Fibrillation Among Blacks from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D).
Figure 1
Manhattan Plots of Admixture Mapping for Incident Atrial Fibrillation Among Blacks from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D).
Figure 1
Manhattan Plots of Admixture Mapping for Incident Atrial Fibrillation Among Blacks from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D).
Figure 2
Manhattan Plots of Admixture Mapping Restricted to Incident Cases of Atrial Fibrillation Among Blacks that Developed the Arrhythmia in the Absence of Baseline Pre-Specified Risk Factors* from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D). *Hypertension, Diabetes, Heart failure, and History of Myocardial Infarction
Figure 2
Manhattan Plots of Admixture Mapping Restricted to Incident Cases of Atrial Fibrillation Among Blacks that Developed the Arrhythmia in the Absence of Baseline Pre-Specified Risk Factors* from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D). *Hypertension, Diabetes, Heart failure, and History of Myocardial Infarction
Figure 2
Manhattan Plots of Admixture Mapping Restricted to Incident Cases of Atrial Fibrillation Among Blacks that Developed the Arrhythmia in the Absence of Baseline Pre-Specified Risk Factors* from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D). *Hypertension, Diabetes, Heart failure, and History of Myocardial Infarction
Figure 2
Manhattan Plots of Admixture Mapping Restricted to Incident Cases of Atrial Fibrillation Among Blacks that Developed the Arrhythmia in the Absence of Baseline Pre-Specified Risk Factors* from CHS (A), ARIC (B), Health ABC (C), and meta-analysis (D). *Hypertension, Diabetes, Heart failure, and History of Myocardial Infarction
Comment in
- The "Double" Paradox of Atrial Fibrillation in Black Individuals.
Stamos TD, Darbar D. Stamos TD, et al. JAMA Cardiol. 2016 Jul 1;1(4):377-9. doi: 10.1001/jamacardio.2016.1259. JAMA Cardiol. 2016. PMID: 27438310 No abstract available.
Similar articles
- Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.
Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LY, Loehr LR, Alonso A. Magnani JW, et al. JAMA Cardiol. 2016 Jul 1;1(4):433-41. doi: 10.1001/jamacardio.2016.1025. JAMA Cardiol. 2016. PMID: 27438320 Free PMC article. - NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.
Whitman IR, Vittinghoff E, DeFilippi CR, Gottdiener JS, Alonso A, Psaty BM, Heckbert SR, Hoogeveen RC, Arking DE, Selvin E, Chen LY, Dewland TA, Marcus GM. Whitman IR, et al. J Am Heart Assoc. 2019 Apr 2;8(7):e010868. doi: 10.1161/JAHA.118.010868. J Am Heart Assoc. 2019. PMID: 30912456 Free PMC article. - Genetic variants associated with risk of atrial fibrillation regulate expression of PITX2, CAV1, MYOZ1, C9orf3 and FANCC.
Martin RI, Babaei MS, Choy MK, Owens WA, Chico TJ, Keenan D, Yonan N, Koref MS, Keavney BD. Martin RI, et al. J Mol Cell Cardiol. 2015 Aug;85:207-14. doi: 10.1016/j.yjmcc.2015.06.005. Epub 2015 Jun 11. J Mol Cell Cardiol. 2015. PMID: 26073630 - Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans.
Delaney JT, Jeff JM, Brown NJ, Pretorius M, Okafor HE, Darbar D, Roden DM, Crawford DC. Delaney JT, et al. PLoS One. 2012;7(2):e32338. doi: 10.1371/journal.pone.0032338. Epub 2012 Feb 23. PLoS One. 2012. PMID: 22384221 Free PMC article. - African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative.
Perez MV, Hoffmann TJ, Tang H, Thornton T, Stefanick ML, Larson JC, Kooperberg C, Reiner AP, Caan B, Iribarren C, Risch N. Perez MV, et al. Am Heart J. 2013 Sep;166(3):566-72. doi: 10.1016/j.ahj.2013.05.024. Epub 2013 Aug 7. Am Heart J. 2013. PMID: 24016508
Cited by
- Racial and Ethnic Differences in the Management of Atrial Fibrillation.
Tamirisa KP, Al-Khatib SM, Mohanty S, Han JK, Natale A, Gupta D, Russo AM, Al-Ahmad A, Gillis AM, Thomas KL. Tamirisa KP, et al. CJC Open. 2021 Sep 13;3(12 Suppl):S137-S148. doi: 10.1016/j.cjco.2021.09.004. eCollection 2021 Dec. CJC Open. 2021. PMID: 34993443 Free PMC article. Review. - Atrial fibrillation: Puzzling out the race paradox.
Ummarino D. Ummarino D. Nat Rev Cardiol. 2016 Aug;13(8):442-3. doi: 10.1038/nrcardio.2016.112. Epub 2016 Jul 7. Nat Rev Cardiol. 2016. PMID: 27383077 No abstract available. - Racial and ethnic disparities in arrhythmia care: A call for action.
Thomas KL, Garg J, Velagapudi P, Gopinathannair R, Chung MK, Kusumoto F, Ajijola O, Jackson LR 2nd, Turagam MK, Joglar JA, Sogade FO, Fontaine JM, Krahn AD, Russo AM, Albert C, Lakkireddy DR. Thomas KL, et al. Heart Rhythm. 2022 Sep;19(9):1577-1593. doi: 10.1016/j.hrthm.2022.06.001. Epub 2022 Jul 14. Heart Rhythm. 2022. PMID: 35842408 Free PMC article. No abstract available. - A study of the clinical application value of ultrasound and electrocardiogram in the differential diagnosis of cardiomyopathy.
Zhao Y, Lin S, Wu J, Lai J, Li L. Zhao Y, et al. Am J Transl Res. 2021 May 15;13(5):5200-5207. eCollection 2021. Am J Transl Res. 2021. PMID: 34150109 Free PMC article. - Machine learning for atrial fibrillation risk prediction in patients with sleep apnea and coronary artery disease.
Silva CAO, Morillo CA, Leite-Castro C, González-Otero R, Bessani M, González R, Castellanos JC, Otero L. Silva CAO, et al. Front Cardiovasc Med. 2022 Dec 7;9:1050409. doi: 10.3389/fcvm.2022.1050409. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36568544 Free PMC article.
References
- Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920–2925. - PubMed
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988. - PubMed
- Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–952. - PubMed
- Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455–2461. - PubMed
- Dewland TA, Olgin JE, Vittinghoff E, Marcus GM. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation. 2013;128(23):2470–2477. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- R01 HL059367/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- N01HC85086/HL/NHLBI NIH HHS/United States
- R01 AG032098/AG/NIA NIH HHS/United States
- 16EIA26410001/AHA/American Heart Association-American Stroke Association/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- R01 HL080295/HL/NHLBI NIH HHS/United States
- HHSN268200782096C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- N01HC85080/HL/NHLBI NIH HHS/United States
- R56 AG023629/AG/NIA NIH HHS/United States
- R01 HL127659/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- N01 AG062101/AG/NIA NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- N01HC55222/HL/NHLBI NIH HHS/United States
- N01 AG062106/AG/NIA NIH HHS/United States
- R01 HL080698/HL/NHLBI NIH HHS/United States
- R01 HL102214/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- N01 AG062103/AG/NIA NIH HHS/United States
- N01HC85082/HL/NHLBI NIH HHS/United States
- R21 HL121348/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- N01HC85083/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- N01HC85079/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
- ZIA AG007390-11/ImNIH/Intramural NIH HHS/United States
- N01HC85081/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical